172 related articles for article (PubMed ID: 11022739)
1. [New anti-androgen and luteinizing hormone releasing hormone antagonist for the treatment of advanced prostate cancer].
Furuya Y; Masai M
Nihon Rinsho; 2000 Jul; 58 Suppl():317-9. PubMed ID: 11022739
[No Abstract] [Full Text] [Related]
2. Combination of somatostatin analogues and dexamethasone (anti-survival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis.
Koutsilieris M; Dimopoulos T; Milathianakis C; Bogdanos J; Karamanolakis D; Pissimissis N; Halapas A; Lembessis P; Papaioannou A; Sourla A
BJU Int; 2007 Jul; 100 Suppl 2():60-2. PubMed ID: 17594363
[No Abstract] [Full Text] [Related]
3. Cancer of the prostate. Mechanisms of action of antiandrogens.
Habenicht UF; Neumann F; el Etreby MF
Acta Urol Belg; 1991; 59(4):1-10. PubMed ID: 1840231
[No Abstract] [Full Text] [Related]
4. Re: luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength.
Marcora S; Oliver S; Callow N; Lemmey A; Stuart N
J Urol; 2005 Nov; 174(5):2068-9. PubMed ID: 16217402
[No Abstract] [Full Text] [Related]
5. Prostate cancer drugs. Making sense of the options.
Mayo Clin Health Lett; 2003 Aug; 21(8):4-5. PubMed ID: 12971308
[No Abstract] [Full Text] [Related]
6. [New possibilities in the hormonal therapy of metastatic carcinoma of the prostate].
Cicin-Sain D; Pasini J
Lijec Vjesn; 1989 Nov; 111(11):405-7. PubMed ID: 2699907
[TBL] [Abstract][Full Text] [Related]
7. [Hormonal treatments of prostate cancer].
Kuhn JM
Rev Prat; 1990 Nov; 40(25):2357-62. PubMed ID: 2124721
[No Abstract] [Full Text] [Related]
8. Hormone agonists and antagonists in the treatment of hormone sensitive breast and prostate cancer.
Nicholson RI; Walker KJ; Davies P
Cancer Surv; 1986; 5(3):463-86. PubMed ID: 3555778
[No Abstract] [Full Text] [Related]
9. Advanced prostate cancer. Hormonal treatment.
de la Haba-Rodríguez J
Tunis Med; 2005 Dec; 83 Suppl 12():71-3. PubMed ID: 16430072
[No Abstract] [Full Text] [Related]
10. Multiple intracrine hormonal targets in the prostate: opportunities and challenges.
Labrie F
BJU Int; 2007 Jul; 100 Suppl 2():48-51. PubMed ID: 17594360
[No Abstract] [Full Text] [Related]
11. [Hormone therapy for prostate cancer].
Théodore C
Bull Cancer; 2004 Jan; 91(1):69-74. PubMed ID: 14975807
[TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced prostate cancer.
Lynch JH
J Fam Pract; 1993 Nov; 37(5):488-94. PubMed ID: 7693859
[TBL] [Abstract][Full Text] [Related]
13. Treatment of advanced cancer of the prostate.
Orovan WL
Can J Surg; 1989 Sep; 32(5):315-6. PubMed ID: 2670160
[No Abstract] [Full Text] [Related]
14. Endocrine therapy for prostate cancer.
Labrie F
Endocrinol Metab Clin North Am; 1991 Dec; 20(4):845-72. PubMed ID: 1778180
[TBL] [Abstract][Full Text] [Related]
15. Incomplete testosterone suppression in prostate cancer.
Crawford ED; Rove KO
N Engl J Med; 2010 Nov; 363(20):1976. PubMed ID: 21067409
[No Abstract] [Full Text] [Related]
16. Hormonal treatment of prostate cancer.
Garnick MB
N Engl J Med; 1999 Mar; 340(10):812-3. PubMed ID: 10075531
[No Abstract] [Full Text] [Related]
17. [New aspects of anti-androgenic therapy of prostatic cancer].
Portnoĭ AS
Urol Nefrol (Mosk); 1985; (3):69-73. PubMed ID: 3892832
[No Abstract] [Full Text] [Related]
18. [Hormone therapy in prostate cancer: clinical results].
Morote-Robles J
Rev Esp Fisiol; 1990 Mar; 46(1):59-62. PubMed ID: 1697693
[TBL] [Abstract][Full Text] [Related]
19. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal anti-androgens: role in treating advanced prostate cancer.
Newton M; Kosier JH
Urol Nurs; 1998 Mar; 18(1):56-7, 83. PubMed ID: 9582897
[No Abstract] [Full Text] [Related]
[Next] [New Search]
